Contents

Search


demeclocycline (Declomycin)

Tradename: Declomycin. Indications: - treatment of syndrome of inappropriate antidiuretic hormone (SIADH) - bacterial infections due to susceptible organisms - plague, tularemia, anthrax, brucellosis, actinomycosis, psittacosis, trachoma, typhus, rickettsialpox, borreliosis, - skin or soft tissue infection - acute otitis media - oral infection - gingivostomatitis - upper respiratory tract infection - pharyngitis, sinusitis - lower respiratory tract infection - pneumonia, bronchitis - intra-abdominal infection - gastrointestinal infection - enterocolitis - cholangitis - urogenital infection - syphilis, gonorrhea, chancroid, lymphogranuloma venereum, donovanosis, yaws - proctitis - eye disease - inclusion conjunctivitis Contraindications: 1) do NOT administer to children < 9 years of age 2) do NOT use in patients with hepatic cirrhosis Caution: avoid prolonged exposure to sunlight Dosage: 1) 150-300 mg PO BID 2) maximum: 1200 mg/day Tabs: 150 & 300 mg. Antimicrobial activity: - Staphylococcus aureus - Chlamydia - Coxiella burnetii - Neisseria gonorrhoeae - Klebsiella - Haemophilus influenzae - Mycoplasma pneumoniae STAPHYLOCOCCUS_AUREUS Adverse effects: 1) not common (1-10%) - photosensitivity - nausea/vomiting - diarrhea 2) uncommon (< 1%) - pericarditis, increased intracranial pressure, pruritus, exfoliative dermatitis, diabetes insipidus, pigmentation of nails, anorexia, abdominal cramps, paresthesia, renal failure, azotemia, anaphylaxis Drug interactions: (see tetracycline)

Interactions

drug interactions

General

tetracycline (Achromycin, Sumycin, Bristacycline)

Properties

MISC-INFO: elimination route LIVER KIDNEY pregnancy-category D safety in lactation -

Database Correlations

PUBCHEM correlations

References

  1. The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
  2. Kaiser Permanente Northern California Regional Drug Formulary, 1998
  3. Medical Knowledge Self Assessment Program (MKSAP) 11, American College of Physicians, Philadelphia 1998
  4. Deprecated Reference
  5. Department of Veterans Affairs, VA National Formulary